| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |